News

Breakthrough in pancreatic cancer research

08 Jun 2026
A major clinical trial has revealed that daraxonrasib, a new targeted oral therapy, could significantly improve outcomes for patients with advanced pancreatic cancer.
[READ MORE]

President urged to intervene over access to lenacapavir

08 Jun 2026
Civil society organisations, including the Treatment Action Campaign are urging Pres Cyril Ramaphosa to intervene with pharmaceutical company Gilead Sciences over access to lenacapavir, a twice-yearly HIV prevention injection being launched in SA.
[READ MORE]

Novo Nordisk takes iDexis to court

08 Jun 2026
On 2 June Business Day reported that Danish pharmaceutical company Novo Nordisk plans to request the High Court to prevent compounding pharmacy iDexis from manufacturing, advertising and distributing products containing semaglutide while regulatory investigations continue.
[READ MORE]

Medical schemes under pressure as claims costs rise

08 Jun 2026
A new Alexander Forbes Health report warns that SA’s medical scheme industry is under increasing financial strain as healthcare costs, claims utilisation and the burden of chronic disease continue to rise.
[READ MORE]

Adcock Ingram referred to Competition Tribunal

08 Jun 2026
The Competition Commission (CC) referred Adcock Ingram Critical Care (AICC) to the Competition Tribunal, alleging that it charged excessive prices for essential kidney dialysis products between July 2019 and June 2024.
[READ MORE]

‘Pharmaceutical procurement practices are weakening localisation efforts’

08 Jun 2026
Trade, Industry and Competition Minister Parks Tau said Government is prioritising pharmaceutical localisation to strengthen industrial capacity and reduce dependence on imports. Vaccine producer Biovac is central to this strategy, with plans to expand production for local and export markets. – Business Times (31 May 2026)
[READ MORE]

SA has fourth highest suicide rate in Africa

02 Jun 2026
SA has recorded the fourth-highest suicide rate in Africa, highlighting the worsening mental health burden facing the country, according to the latest data from the World Health Organisation’s Global Health Observatory. – Times Live (1 June 2026)
[READ MORE]

CoN decision will not weaken NHI scheme, says Motsoaledi

02 Jun 2026
The Constitutional Court’s recent decision to strike down the certificate-of-need CoN provisions would not weaken the National Health Insurance (NHI) scheme, Health Minister Aaron Motsoaledi told Chris Baron in an interview (Sunday Times 31 May 2026)
[READ MORE]

‘Pharmaceutical procurement practices are weakening localisation efforts’

02 Jun 2026
Trade, Industry and Competition Minister Parks Tau said Government is prioritising pharmaceutical localisation to strengthen industrial capacity and reduce dependence on imports. Vaccine producer Biovac is central to this strategy, with plans to expand production for local and export markets. – Business Times (31 May 2026)
[READ MORE]

Removal of medical tax credits on the cards

17 Oct 2025
“With significant legal and logistical uncertainty still surrounding the NHI's implementation, making precipitous changes to the tax system could have unforeseen and damaging consequences for millions of South Africans.” - Business Day(17 October 2025)
[READ MORE]

Pharma faces billions in costs due to new tariffs

29 Jul 2025
“The pharmaceutical industry is bracing for a significant financial blow, with analysts forecasting costs of between $13bn and $19bn following the revelation that a new transatlantic trade deal will subject branded medicines to a hefty 15% tariff.” – Reuters (28 July 2025)
[READ MORE]

Life Healthcare backs collaboration to tackle healthcare crisis

27 Nov 2024
Life Healthcare CEO Peter Wharton-Hood has backed a call for greater collaboration between the government and private healthcare providers to address South Africa’s pressing healthcare challenges. This follows a proposal by Netcare CEO Richard Friedland, who suggested adding healthcare as the fourth pillar in an existing government-business partnership focused on revitalising the economy.
[READ MORE]

Discovery Life claims back to pre-Covid levels

19 Apr 2024
“Discovery Life distributed R10.3bn to its clients, a decrease from the R11bn paid the previous year,” reported Business Day (19April 2024)
[READ MORE]

Hundreds of websites found selling fake weight-loss drugs

16 Apr 2024
Reuters reported on 15 April that the cybersecurity company BrandShield has shut down over 250 websites selling counterfeit versions of popular drugs used for weight loss and diabetes treatment within the GLP-1 class.
[READ MORE]

RAF bid to appeal judgment on claim requirements

06 Dec 2023
On 5 December 2023 the Pretoria High Court rejected the Road Accident Fund’s (RAF) request to reconsider a previous verdict from November, reported Business Day. “The ruling mandated eliminating the stringent new requirements for filing claims outlined in a 2021 board notice.”
[READ MORE]

Page 1 of 2 Next > >>

1	Disclaimer
	HEALTHMAN, do not guarantee the availability of services offered on this website ("the Services") or the accuracy of the information and/or images on this website. We make no representations or warranties, whether express or implied, and assume no liability or responsibility for the proper performance of this website and/or the Services and/or the information and/or images contained on this website, and the Services are thus used at your own risk. In particular we make no warrantee that the Services will meet your requirements, be uninterrupted, timely, and secure or error free.

2	Indemnification
	You, the user, accordingly indemnify and hold us harmless against all and any loss, liability, actions, suites, proceedings, costs, demands and damages of all and every kind, (including direct, indirect, special or consequential damages), and whether in an action based on contract, negligence or any other action, arising out of or in connection with the failure or delay in the performance of the Services offered on this website, or the use of the information and/or images available on this website.

3	Use of Services
	3.1	You may only use the Services for lawful purposes and you warrant that you shall not:
		3.1.1	1 other than for your personal and non-commercial use, store on your computer, or print copies of extracts from this website, and you may not, other than for your personal and non-commercial use, "mirror" or cache information provided via this website on your own server, or copy, adapt, modify or re-use the text or graphics from this website without prior written permission from HEALTHMAN.

4	Privacy
	4.1	Whilst your name and particulars which are supplied to us when registering for some of the Services will not automatically be made available to anyone, we nevertheless reserve the right to make information available to the authorities if required by law.
	4.2	We will not sell or rent any personally identifiable information about you to any third party. However monitoring or recording of your registration details may take place for business purposes to the extent permitted by law, such as for example quality control and training for the purposes of improving our Services. However, in these situations, we will not disclose information that could be used to personally identify you.
	4.3	We will adhere to our privacy policy the salient terms of which are available for you to link to and read from the home page of this website.
	4.4	You must notify us immediately should any of your information change.

5	Intellectual Property Rights
	You acknowledge that we own the intellectual property rights in and to this website, and that the unauthorized use thereof is expressly prohibited. The word or mark "HEALTHMAN", and "e2", however represented, including stylized representation, all associated logos and symbols and combinations of any of the a foregoing with another word or mark, used on this site, are the trademarks of HEALTHMAN.

6	Password
	You shall keep your password secure and warrant that no other person shall use the Services utilizing your password, and you acknowledge further that you are responsible for ensuring that no unauthorized access to the Services is obtained using your password, and that you will be liable for all such activities conducted pursuant to such use, whether authorized or not.

7	Termination and Variation
	We reserve the right to terminate the Services to you in particular, or to the public in general, without notice or reason, or to revise these terms and conditions at any time. Such changes will be posted on this website and be deemed to have been accepted by you if you continue using the Services. The obligation therefore is on you to review these terms and conditions at regular intervals.

8.	General
	8.1	These terms and conditions will be governed by and construed in accordance with the laws of South Africa.
	8.2	These terms and conditions are severable, in that if any provision is determined to be illegal or unenforceable by any court of competent jurisdiction, then such provision shall be deemed to have been deleted without affecting the remaining provisions of the terms and conditions.
	8.3	Our failure to exercise any particular rights or provision of these terms and conditions shall not constitute a waiver of such right or provision, unless acknowledged and agreed to by us in writing.
	8.4	These terms and conditions, as varied by us from time to time pursuant to clause 7, above constitute the sole agreement between yourself and ourselves.

1.	Content of Customer Information
	HEALTHMAN shall ensure that:
	1.1	customer information shall be obtained only for the purpose of delivering and improving the Services and will not be processed in any manner incompatible with this purpose;
	1.2	customer information shall be adequate, relevant and not excessive in relation to the abovementioned purpose for which it is collated and/or processed;
	1.3	customer information shall be accurate, and where necessary, kept up to date and reasonable steps shall be taken to ensure that information which is inaccurate and/or incomplete, having regard to the purpose for which it was collected, is erased or rectified;
	1.4	customer information shall be kept in a format which permits identification for no longer than is necessary for the purpose for which the information was collected or processed.

2	Customer Consent
	Customer information may only be processed if:
	2.1	the customer has unambiguously given his consent; or
	2.2	processing is necessary for:
		2.2.1	the performance of a contract to which the customer is a party; or
		2.2.2	in order to take steps at the request of the customer prior to entering into a contract; or
		2.2.3	for compliance with a legal obligation to which HEALTHMAN is subject; or
		2.2.4	the performance of a task carried out in the public interest or in the exercise of official authority vested in the recipient; or
		2.2.5	for purposes of the legitimate interest pursued by HEALTHMAN, except where such interest is overridden by the interest for fundamental rights as reflected in the constitution.

3.	Access to Customer Information
	HEALTHMAN shall ensure that:
	3.1	access to, or disclosure of customer information will not be authorized without the documented commitment of the intended recipient so as to maintain confidentiality and the rightful use of such information;
	3.2	access to customer information by HEALTHMAN personnel, contract workers, consultants, service providers or suppliers will be restricted to the level of access needed to effectively perform delegated or contracted duties and/or the level of service needed to render a reliable and effective service to HEALTHMAN customers.

4.	Preventative Measures
	HEALTHMAN shall ensure that appropriate technical and organizational measures shall be taken against the unauthorized access, processing or disclosure of customer information